110 related articles for article (PubMed ID: 10461839)
1. Reduced susceptibility in laboratory-selected mutants of Aspergillus fumigatus to itraconazole due to decreased intracellular accumulation of the antifungal agent.
Manavathu EK; Vazquez JA; Chandrasekar PH
Int J Antimicrob Agents; 1999 Aug; 12(3):213-9. PubMed ID: 10461839
[TBL] [Abstract][Full Text] [Related]
2. Isolation and in vitro susceptibility to amphotericin B, itraconazole and posaconazole of voriconazole-resistant laboratory isolates of Aspergillus fumigatus.
Manavathu EK; Abraham OC; Chandrasekar PH
Clin Microbiol Infect; 2001 Mar; 7(3):130-7. PubMed ID: 11318811
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of the broth micro- and macro-dilution techniques for the determination of the in vitro susceptibility of Aspergillus fumigatus.
Manavathu EK; Alangaden GJ; Lerner SA
Can J Microbiol; 1996 Sep; 42(9):960-4. PubMed ID: 8864219
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592).
Manavathu EK; Cutright JL; Loebenberg D; Chandrasekar PH
J Antimicrob Chemother; 2000 Aug; 46(2):229-34. PubMed ID: 10933645
[TBL] [Abstract][Full Text] [Related]
5. In-vitro and in-vivo susceptibility of Aspergillus fumigatus to a novel conjugated styryl ketone.
Manavathu EK; Dimmock JR; Vashishtha SC; Cutright J; Chandrasekar PH
J Antimicrob Chemother; 1998 Nov; 42(5):585-90. PubMed ID: 9848441
[TBL] [Abstract][Full Text] [Related]
6. In-vitro isolation and antifungal susceptibility of amphotericin B-resistant mutants of Aspergillus fumigatus.
Manavathu EK; Alangaden GJ; Chandrasekar PH
J Antimicrob Chemother; 1998 Jun; 41(6):615-9. PubMed ID: 9687099
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole, and amphotericin B.
Abraham OC; Manavathu EK; Cutright JL; Chandrasekar PH
Diagn Microbiol Infect Dis; 1999 Jan; 33(1):7-11. PubMed ID: 9990469
[TBL] [Abstract][Full Text] [Related]
8. Does hydrocortisone modify the in vitro susceptibility of Aspergillus fumigatus to itraconazole and amphotericin B?
Ramondenc I; Pinel C; Ambroise-Thomas P; Grillot R
Med Mycol; 1998 Apr; 36(2):69-73. PubMed ID: 9776816
[TBL] [Abstract][Full Text] [Related]
9. In-vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates.
Verweij PE; Mensink M; Rijs AJ; Donnelly JP; Meis JF; Denning DW
J Antimicrob Chemother; 1998 Sep; 42(3):389-92. PubMed ID: 9786480
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus.
Cuenca-Estrella M; Rodríguez-Tudela JL; Mellado E; Martínez-Suárez JV; Monzón A
J Antimicrob Chemother; 1998 Oct; 42(4):531-3. PubMed ID: 9818755
[TBL] [Abstract][Full Text] [Related]
11. First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey.
Özmerdiven GE; Ak S; Ener B; Ağca H; Cilo BD; Tunca B; Akalın H
J Infect Chemother; 2015 Aug; 21(8):581-6. PubMed ID: 26048062
[TBL] [Abstract][Full Text] [Related]
12. Concomitant occurrence of itraconazole-resistant and -susceptible strains of Aspergillus fumigatus in routine cultures.
Ahmad S; Joseph L; Hagen F; Meis JF; Khan Z
J Antimicrob Chemother; 2015 Feb; 70(2):412-5. PubMed ID: 25326091
[TBL] [Abstract][Full Text] [Related]
13. Comparison between Aspergillus fumigatus conidia and hyphae susceptibilities to amphotericin B, itraconazole, and voriconazole by use of the mold rapid susceptibility assay.
Wetter TJ; Hazen KC; Cutler JE
Med Mycol; 2005 Sep; 43(6):525-32. PubMed ID: 16323310
[TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibility of respiratory isolates of Aspergillus species to itraconazole and amphotericin B. acquired resistance to itraconazole.
Chryssanthou E
Scand J Infect Dis; 1997; 29(5):509-12. PubMed ID: 9435042
[TBL] [Abstract][Full Text] [Related]
15. Modification of rapid susceptibility assay for antifungal susceptibility testing of Aspergillus fumigatus.
Wetter TJ; Hazen KC; Cutler JE
J Clin Microbiol; 2003 Sep; 41(9):4252-8. PubMed ID: 12958253
[TBL] [Abstract][Full Text] [Related]
16. Correlation between the E test and the CLSI M-38 A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.
Guinea J; Peláez T; Alcalá L; Bouza E
Diagn Microbiol Infect Dis; 2007 Mar; 57(3):273-6. PubMed ID: 17141455
[TBL] [Abstract][Full Text] [Related]
17. In-vitro susceptibility of Aspergillus spp. isolates to amphotericin B and itraconazole.
Dannaoui E; Persat F; Monier MF; Borel E; Piens MA; Picot S
J Antimicrob Chemother; 1999 Oct; 44(4):553-5. PubMed ID: 10588320
[TBL] [Abstract][Full Text] [Related]
18. Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection.
Denning DW; Radford SA; Oakley KL; Hall L; Johnson EM; Warnock DW
J Antimicrob Chemother; 1997 Sep; 40(3):401-14. PubMed ID: 9338494
[TBL] [Abstract][Full Text] [Related]
19. Acquired itraconazole resistance in Aspergillus fumigatus.
Dannaoui E; Borel E; Monier MF; Piens MA; Picot S; Persat F
J Antimicrob Chemother; 2001 Mar; 47(3):333-40. PubMed ID: 11222566
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma.
Chen J; Li H; Li R; Bu D; Wan Z
J Antimicrob Chemother; 2005 Jan; 55(1):31-7. PubMed ID: 15563516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
